Crossmark

Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trial

Crossref DOI link: https://doi.org/10.1016/j.aller.2017.12.001

Published Print: 2018-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rubio-Gomis, E.

Martinez-Mir, I.

Morales-Olivas, F.J.

Martorell-Aragones, A.

Palop-Larrea, V.

Bernalte-Sesé, A.

Cerda-Mir, J.C.

Polo-Martín, P.

Febrer, I.

Aranda-Grau, L.

Llosa-Cortes, I.

Tejedor-Sanz, Mª.J.

Julia-Benito, J.C.

Alvarez-de-Laviada-Mulero, T.

Planelles-Cantarino, Mª.V.

Apolinar-Valiente, E.

Loriente-Tur, M.

Abella-Bazataqui, A.M.

Alvarez-Gonzalez, I.

Morales-Carpi, C.

Burches-Greus, Mª.E.

Ferrer-Bautista, A.B.

Felix-Toledo, R.

Marmaneu-Laguia, D.

Garcia-Martinez, V.E.

Beltran-Marques, Mª.A.

Rodriguez-Gracia, B.
License Information

Text and Data Mining valid from 2018-07-01
More Information

This article is maintained by: Elsevier

Article Title: Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trial

Journal Title: Allergologia et Immunopathologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aller.2017.12.001

Content Type: article

Copyright: © 2018 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.